Phase II Study of Daratumumab Pre-Mobilization and Post-ASCT in Multiple Myeloma
Clinical trial NCT04230031 · WITHDRAWN
Trial details
- NCT number
- NCT04230031
- Sponsor
- Wake Forest University Health Sciences
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-02
- Primary completion
- 2027-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.